glp-1 cost Survey Finds: Users Cut Food Costs Nearly 30% Medicare Spending on Ozempic and
Description
Medicare Part D has changed so much since 2024

Tirzepatide significantly reduced food intake and body weight
Our findings confirm that longer diabetes duration is associated with a lower glycaemic response to GLP-1 RAs [3, 6, 16], probably due to declining beta cell function, as intact insulin secretion is necessary for a robust glycaemic response to this drug class [1, 3]
(Medicare Policy Initiative) FDA approvals matter: When a GLP-1 drug gains an FDA label for something like reducing heart attack risk (beyond weight loss), that opens up possible Medicare Part D coverage for that use
